###begin article-title 0
Neurotrophin/Trk receptor signaling mediates C/EBPalpha, -beta and NeuroD recruitment to immediate-early gene promoters in neuronal cells and requires C/EBPs to induce immediate-early gene transcription
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Extracellular signaling through receptors for neurotrophins mediates diverse neuronal functions, including survival, migration and differentiation in the central nervous system, but the transcriptional targets and regulators that mediate these diverse neurotrophin functions are not well understood.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 316 321 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 438 447 431 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 451 458 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 572 576 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 693 700 682 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 721 727 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 731 737 720 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 771 774 760 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 776 781 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 785 790 774 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 928 933 917 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebp </italic>
###xml 937 942 926 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ntrk </italic>
###xml 951 955 <span type="species:ncbi:10090">mice</span>
We have identified the immediate-early (IE) genes Fos, Egr1 and Egr2 as transcriptional targets of brain derived neurotrophic factor (BDNF)/TrkB signaling in primary cortical neurons, and show that the Fos serum response element area responds to BDNF/TrkB in a manner dependent on a combined C/EBP-Ebox element. The Egr1 and Egr2 promoters contain homologous regulatory elements. We found that C/EBPalpha/beta and NeuroD formed complexes in vitro and in vivo, and were recruited to all three homologous promoter regions. C/EBPalpha and NeuroD co-operatively activated the Fos promoter in transfection assays. Genetic depletion of Trk receptors led to impaired recruitment of C/EBPs and NeuroD in vivo, and elimination of Cebpa and Cebpb alleles reduced BDNF induction of Fos, Egr1 and Egr2 in primary neurons. Finally, defective differentiation of cortical dendrites, as measured by MAP2 staining, was observed in both compound Cebp and Ntrk knockout mice.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
We here identify three IE genes as targets for BDNF/TrkB signaling, show that C/EBPalpha and -beta are recruited along with NeuroD to target promoters, and that C/EBPs are essential mediators of Trk signaling in cortical neurons. We show also that C/EBPs and Trks are required for cortical dendrite differentiation, consistent with Trks regulating dendritic differentiation via a C/EBP-dependent mechanism. Finally, this study indicates that BDNF induction of IE genes important for neuronal function depends on transcription factors (C/EBP, NeuroD) up-regulated during neuronal development, thereby coupling the functional competence of the neuronal cells to their differentiation.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 716 717 716 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
The influence of growth factors, as well as transcription factors, on cell fate determination and differentiation is well established. Brain derived neurotrophic factor (BDNF) affects neuronal cortical development by signaling through its cognate tyrosine kinase receptor, TrkB. Together they regulate many cellular functions during and after the development of the nervous system [1-4]. In particular, we have reported that TrkB, via the activation of the Ras/Mitogen activated protein kinase (MAPK) and Phosphatidylinositol-3 kinase/cellular homolog of the viral oncogene v-Akt (PI3K/AKT) pathways, regulates functions throughout the formation of the cerebral cortex, including neuronal dendritic differentiation [5]. While several transcription factors have been found to respond to activation of TrkB and other Trk family receptors, it is not well understood how Trk signaling interacts with the transcription factors regulating neuronal differentiation to activate specific target genes required during the different phases of neuronal development and, subsequently, in neuronal function.
###end p 9
###begin p 10
###xml 716 717 716 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 718 719 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 880 881 880 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1150 1151 1150 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
The neurogenic basic helix-loop-helix (bHLH) transcription factors have been shown to be important intrinsic regulators of neural fate determination and differentiation. There are at least two categories of bHLH transcription factors that mediate neurogenesis: proneural bHLHs (Neurogenins and Mash family proteins), which are involved in initiating neurogenesis, and neuronal differentiation factors (members of the NeuroD/Nex family), which are important for terminal differentiation. Studies in mice lacking NeuroD/Nex family members indicate that they are required not only for the survival of early differentiating granule neurons in the hippocampus and cerebellum, but also for their terminal differentiation [6,7]. Specifically, NeuroD selectively promotes dendrite, but not axonal, morphogenesis in granule neurons through its phosphorylation at distinct sites by CamKII [8]. These factors form heterodimers with ubiquitously expressed bHLH proteins, such as E12 and E47, and activate gene expression programs through interaction, via their basic domain, with DNA sequences containing the core hexanucleotide motif CANNTG, known as the Ebox [9,10]. It is still unknown which extracellular signals or intracellular mechanisms are involved in the regulation of bHLH factor function.
###end p 10
###begin p 11
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 613 622 613 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 712 717 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 731 740 731 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in utero </italic>
The CCAAT/enhancer binding protein (C/EBP) family of transcription factors couples growth factor signal transduction with numerous cellular responses, including cellular differentiation in a variety of non-neuronal tissues [11,12]. The expression of C/EBPs has also been found to change during a number of physiological and pathophysiological conditions in response to extracellular signals, such as hormones, mitogens, and cytokines [12]. Recently, a Mitogen and extracellular signal regulated kinase (MEK)-C/EBP signaling cascade has been implicated in the commitment of progenitor cells toward a neuronal fate in vitro through the inhibition of either MEK or C/EBPs using dominant negative forms [13]. Paquin et al. [14], using in utero electroporation to manipulate cortical precursors, have suggested that MEK-mediated phosphorylation of C/EBPs is essential for neuronal fate determination. Thus far, however, no genetic model has demonstrated an effect for MEK1/2 or C/EBPs on neuronal lineage commitment or differentiation.
###end p 11
###begin p 12
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 184 191 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 228 231 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 233 238 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 242 247 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 566 573 559 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
We here identify Fos, Egr1 and Egr2 as genes that are regulated by BDNF/TrkB in a C/EBP-dependent manner. We identify a novel complex between C/EBPalpha/beta and NeuroD, and find that in vivo, these factors are recruited to the Fos, Egr1 and Egr2 promoters in a Trk-dependent manner. Genetic C/EBP depletion leads to a cortical dendritic neuronal differentiation defect, reminiscent of that seen in the absence of multiple TrkB/C alleles, consistent with the idea that Trk signaling through C/EBP-NeuroD complexes mediates terminal cortical neuronal differentiation in vivo.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1</italic>
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
BDNF induces Egr1, Egr2 and Fos expression in primary cortical neurons
###end title 14
###begin p 15
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1</italic>
###xml 426 431 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 435 438 435 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 602 603 602 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b&#8211;d</xref>
###xml 584 589 <span type="species:ncbi:10090">mouse</span>
To identify genes regulated by BDNF signaling through TrkB in neuronal cells, primary cortical neurons derived from E15.5 embryonic forebrain (when neurogenesis is at its peak) were stimulated with BDNF and their gene expression compared to that of untreated control cultures by microarray analysis. Among the most highly regulated genes was a group encoding immediate-early (IE) transcription factors that consisted of Egr1, Egr2 and Fos. For all three it was found that BDNF induction was reduced when the binding site for the Shc adaptor on the TrkB receptor was mutated (for this mouse strain see [5,15], and Materials and methods), consistent with a common regulatory mechanism underlying their upregulation (Figure 1a). The Shc site-dependent induction of these genes was confirmed by quantitative real time PCR (qRT-PCR) (Figure 1b-d).
###end p 15
###begin p 16
###xml 70 74 70 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB</italic>
###xml 124 128 124 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB</italic>
###xml 136 139 136 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHC</italic>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHC </italic>
###xml 136 144 136 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>SHC</italic>/<italic>SHC </italic></sup>
###xml 259 263 259 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">SHC </sup>
###xml 432 438 432 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b-d) </bold>
###xml 518 522 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB</italic>
###xml 522 526 522 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 529 533 529 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB</italic>
###xml 533 536 533 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHC</italic>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHC </italic>
###xml 533 541 533 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>SHC</italic>/<italic>SHC </italic></sup>
###xml 700 705 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 710 714 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 723 728 723 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
IE gene expression upon BDNF stimulation of primary cortical neurons. (a) Comparison of selected group of genes between trkB+/+ and trkBSHC/SHC mutant mice. The mRNA for the Affymetrix analysis was obtained from E15.5 primary cortical neurons with +/+ or TrkBSHC receptors that were either left unstimulated or stimulated with 50 ng/ml of BDNF for 1 hour after 1DIV. The fold change was averaged from three independent experiments. (b-d) qRT-PCR analysis of the selected BDNF regulated genes. Total mRNA obtained from trkB+/+ or trkBSHC/SHC primary cortical neurons, either left untreated or treated with 50 ng/ml of BDNF at different time points, were analyzed by qRT-PCR using primers specific for Egr1 (b), Fos (c), and Egr2 (d). After normalization to GAPDH, mRNA levels were expressed relative to the levels obtained from wild-type unstimulated cortical neurons, which were given the arbitrary value of 1. Average values and standard errors were obtained from three independent animals.
###end p 16
###begin title 17
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
A combined C/EBP site-E-box mediates Fos induction by BDNF
###end title 17
###begin p 18
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 461 465 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 760 761 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 786 787 786 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 851 852 851 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 967 973 967 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 977 982 977 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb</italic>
###xml 995 1002 995 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neurod </italic>
###xml 1133 1137 1133 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a&#8211;d</xref>
###xml 1185 1189 1181 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 1346 1348 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3e</xref>
In order to identify the transcriptional mechanism by which BDNF induces IE gene transcription we initially established that a reporter construct carrying 700 base-pairs (bp) of the Fos promoter was induced by BDNF when transiently transfected into cultures of primary cortical neurons (Figure 2a). We next analyzed the role of the area of the Fos promoter surrounding the serum response element (SRE), as this is the most highly conserved part of the proximal Fos promoter. The SRE area contains overlapping binding sites for serum response factor (SRF), C/EBP, E-proteins and activating protein-1 (AP-1)/activating transcription factor (ATF). By transient transfection analysis, the simultaneous mutation of the Ebox and C/EBP site (see supplementary Figure 1 in Additional data file 1 and Supplemental materials and methods in Additional data file 2 for analysis) was found to significantly decrease promoter induction by BDNF (Figure 2b). We determined that both Cebpa and Cebpb, as well as Neurod (encoding the Ebox protein Beta2/NeuroD), were upregulated in neuroblasts cultured under neural differentiation conditions (Figure 3a-d), and that C/EBPalpha and NeuroD cooperated in Fos promoter activation, in a manner dependent on the presence of their cognate binding sites, in a heterologous cell line not expressing these proteins (Figure 3e). Here it should be noticed that other C/EBPalpha and NeuroD sites might be present in the promoter or in the vector backbone, providing residual activation after mutation of the identified C/EBPalpha and NeuroD sites.
###end p 18
###begin p 19
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 111 115 111 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hFos</italic>
###xml 331 335 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 541 545 538 542 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 621 625 618 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 750 754 747 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 1005 1009 997 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 1457 1461 1449 1453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 1484 1488 1476 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 347 352 <span type="species:ncbi:10090">mouse</span>
###xml 357 362 <span type="species:ncbi:9606">human</span>
A combined C/EBP binding site-E-box mediates Fos induction by BDNF/TrkB signaling in primary cortical neurons. (a) Time course of luciferase activity based upon BDNF stimulation (50 ng/ml) of E15.5 wild-type (wt) cortical neurons transfected with a human Fos (hFos) promoter luciferase reporter plasmid (the proximal region of the Fos promoter in mouse and human is identical; see supplemental Figure 2a in Additional data file 1) and a pRSV-beta-gal plasmid. Maximum luciferase activity was found between 2 and 4 hours of BDNF stimulation. (b) The combined C/EBP and Ebox sites are fundamental for the activation of the Fos promoter downstream of BDNF/TrkB. E15.5 wild-type primary cortical neurons were transfected with either wild-type or mutated Fos promoter luciferase reporter plasmids and pRSV-beta-gal, and stimulated with 50 ng/ml of BDNF for 2 hours. Data shown are the average of three independent experiments, and results are indicated as the mean +/- standard error. Cells transfected with a Fos promoter mutated in both the C/EBP and the Ebox binding sites (pMcebp/ebox) showed a significant decrease in luciferase activity (*p < 0.005 relative to pWT). Instead, cortical neurons transfected with a plasmid mutated in the SRE and C/EBP binding site (pMSRF/cebp) revealed a significant increment in the activation of the promoter (*p < 0.005 relative to pWT). No significant difference in luciferase activity was observed between the wild-type Fos promoter (pWT) and the Fos promoter mutated at the Ebox alone (pMebox).
###end p 19
###begin p 20
###xml 107 111 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 121 127 114 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a,b) </bold>
###xml 325 329 318 322 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 348 356 341 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 360 367 353 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neurod </italic>
###xml 587 597 580 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ubiquitin </italic>
###xml 725 729 718 722 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 848 858 841 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ubiquitin </italic>
###xml 876 880 869 873 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e) </bold>
###xml 969 973 958 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 1037 1041 1026 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 1481 1485 1458 1462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
C/EBPalpha/beta and NeuroD transcription factors are co-expressed in neurons and cooperate to activate the Fos promoter. (a,b) Immunocytochemical analysis of cortical neuron progenitors cultured at E12.5, and stained with Nestin antibodies after 2DIV (a) or antibodies against the differentiation marker MAP2 after 4DIV (b). (c) RT-PCR analysis of Cebpa/b and Neurod in cortical progenitors. Primary cortical neuron progenitors from two different preparations were cultured at E12.5 and harvested for total mRNA after 2DIV (lanes 1 and 2), 4DIV (lanes 3 and 4), or 6DIV (lanes 5 and 6). Ubiquitin was used to control the levels of mRNA. Lanes 7 and 8 are mRNA samples without reverse transcriptase (RT). Lane 9, no template. (d) RT-PCR shown in (c) was quantified by densitometric analysis and is shown as the ratio of transcription factor (TF) to ubiquitin expression level. (e) Cooperation between C/EBPalpha and NeuroD transcription factors in the activation of the Fos promoter. NIH3T3 cells were transfected with either a wild-type Fos reporter plasmid (pWT, blue bars) or a reporter plasmid in which both the C/EBP and the Ebox binding sites were mutated (pMcebp/ebox, red bars), in the absence (lanes 1 and 5) or presence of a plasmid containing either C/EBPalpha (lanes 2 and 6), NeuroD (lanes 3 and 7) or a combination of both plasmids C/EBPalpha and NeuroD (lanes 4 and 8). Co-transfection of C/EBPalpha and NeuroD significantly increased the activation of the wild-type Fos promoter (lane 4) compared to C/EBPalpha or NeuroD alone (p < 0.0001 in both cases). This cooperation was significantly reduced (p < 0.0001) upon mutation of the C/EBP and Ebox binding sites (lane 8). Luciferase activity was normalised to beta-gal activity. The relative luciferase activity represents the mean value of at least four independent experiments.
###end p 20
###begin title 21
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
C/EBPs and NeuroD are recruited to IE gene promoters in vivo
###end title 21
###begin p 22
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 236 243 236 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 446 459 439 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a, c, d, f&#8211;h</xref>
###xml 581 585 574 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 618 623 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 855 860 848 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b, e</xref>
Sequence alignment identified homologies to the Fos SRE area in the Egr1 and Egr2 promoters (supplemental Figure 2 in Additional data file 1). To understand if these homologous promoter regions bound C/EBPs and NeuroD in neuronal cells in vivo, chromatin immunoprecipitation (ChIP) analysis was performed on embryonic forebrains. This showed that C/EBPalpha, C/EBPbeta and NeuroD were all present on the three homologous promoter regions (Figure 4a, c, d, f-h). As a control for specificity of the ChIP, a similar analysis was performed on two unrelated sequences derived from the Fos 3' untranslated region (UTR) and Egr1 exon 4; these regions showed no detectable binding of C/EBPs or NeuroD, whereas antibodies against histone 3 (H3) and acetyl-H3 (Ac-H3) were able to precipitate these amplicons, confirming the quality of the input chromatin (Figure 4b, e).
###end p 22
###begin p 23
###xml 44 47 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 49 53 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1</italic>
###xml 59 64 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 74 81 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 83 91 76 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a,d,g) </bold>
###xml 91 99 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 112 115 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 117 121 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1</italic>
###xml 126 131 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 228 231 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 233 237 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1</italic>
###xml 243 248 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 840 846 819 825 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b,e) </bold>
###xml 980 984 959 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 1035 1040 1014 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 1092 1100 1071 1079 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c,f,h) </bold>
###xml 1188 1192 1167 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 1197 1202 1176 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 1211 1216 1190 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 1381 1383 1360 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1406 1408 1385 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1419 1421 1398 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1432 1436 1411 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1</italic>
###xml 1439 1441 1418 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1453 1455 1432 1434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1467 1470 1446 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 1473 1475 1452 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1487 1489 1466 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1501 1505 1480 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2</italic>
C/EBPalpha/beta and NeuroD are bound to the Fos, Egr1, and Egr2 promoters in vivo. (a,d,g) In vivo detection of Fos, Egr1, or Egr2 promoter occupancy by C/EBPalpha/beta and NeuroD using ChIP analysis. The schemes illustrate the Fos, Egr1, and Egr2 promoter regions amplified by PCR in their 5' UTR (nucleotides -453 to -126, 1220 to 1361, and -96 to 72, respectively). The large black boxes indicate the predicted DNA binding sites (bs) for C/EBP and NeuroD. The small boxes indicate the position of the primers used for PCR amplification. ChIP assays were performed using E16.5 wild-type forebrain lysates and antibodies against NeuroD, C/EBPalpha and beta, and demonstrated that these proteins are recruited to the three promoters. Input corresponds to PCR reactions containing 0.5% of the total amount of chromatin used in IP reactions. (b,e) To confirm the specificity of the results, IPs from each antibody were also analyzed by PCR with primers specific for a region of the Fos gene located in the 3' UTR, or for a region of the Egr1 gene located in exon 4 as indicated in the schemes. (c,f,h) qPCR analysis was used to quantify the relative amounts of DNA obtained by ChIP for the Fos (c), Egr1 (f), and Egr2 (h) promoters. DNA quantities (expressed as percentages of input) were compared for specific IPs versus Ig IP samples (see Materials and methods). The corresponding p values are indicated: *p < 0.002, **p < 0.02 for Egr1; *p < 0.0001, **p < 0.005 for Fos; *p < 0.0001, **p < 0.002 for Egr2. Error bars represent the standard error based on three independent experiments.
###end p 23
###begin title 24
C/EBPs mediate BDNF induction of IE genes in primary cortical neurons
###end title 24
###begin p 25
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 337 343 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 347 353 340 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 367 371 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a&#8211;c</xref>
###xml 399 405 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 409 415 402 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 462 464 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 577 582 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 582 585 575 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 585 590 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb</italic>
###xml 590 594 583 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 647 652 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 652 655 645 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 655 660 648 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb</italic>
###xml 660 664 653 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 667 672 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 672 675 665 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 675 680 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb</italic>
###xml 680 684 673 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1028 1034 1021 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 1038 1044 1031 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 1060 1062 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5d</xref>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
The above analysis showed that the Fos, Egr1 and Egr2 promoters contain homologous regulatory sequences, and that all three recruit C/EBPalpha, -beta and NeuroD. To determine whether C/EBPs play a direct role in the BDNF regulation of these genes, we cultured primary cortical neurons from mice carrying two or three null alleles of the Cebpa and Cebpb genes (Figure 5a-c); inactivation of all four Cebpa and Cebpb alleles leads to embryonic lethality at E10.5 [16]. This analysis showed that a significant decrease in expression after BDNF stimulation was observed already in Cebpa+/-Cebpb+/- cells, whereas further loss of an additional allele (Cebpa+/-Cebpb-/- or Cebpa-/-Cebpb+/- cells) led to a further reduction, resulting in loss of 70% to 90% of the BDNF-induced level of gene expression. This was not due to loss of BDNF/TrkB signaling, as BDNF-mediated induction of the MAPK pathway (as measured by p42/p44 MAPK phosphorylation) and the PI3K/AKT pathway (as measured by AKT phosphorylation) were unaffected by loss of Cebpa and Cebpb alleles (Figure 5d).
###end p 25
###begin p 26
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 82 90 82 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 111 117 111 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-c) </bold>
###xml 242 250 242 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 431 436 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gapdh</italic>
###xml 602 604 602 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 671 675 671 675 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 745 752 745 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b</italic>
###xml 827 835 827 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
BDNF dependent expression of Fos, Egr1 and Egr2 is affected in mice with compound Cebpa/b null mutant alleles. (a-c) qRT-PCR analysis was performed on mRNA obtained from E13.5 primary cortical neurons of wild-type and different genotypes for Cebpa/b null mutants as indicated. After 3DIV, the neurons were either left unstimulated or stimulated with 5 ng/ml of BDNF for 1 hour. The mRNA levels are relative, after normalization to gapdh, considering the levels for the stimulated wild-type cortical neurons as 100. Error bars represent the standard error obtained from three animals for each genotype. P < 0.0001 for all induced samples of mutants compared to wild type. (d) BDNF/TrkB dependent signaling in primary cortical neurons with mutant Cebpa/b. E13.5 cortical neurons derived from wild-type or different genotypes for Cebpa/b null mutants after 3DIV were either left unstimulated or stimulated with 5 ng/ml of BDNF for 5 minutes. Cell lysates were subjected to SDS-PAGE followed by immunoblotting with an antibody against the phosphorylated forms of ERK (p42/p44). The blots were re-probed with an anti-phospho-AKT antibody, and a second time with an antibody against alpha-tubulin to control for the amount of protein loaded.
###end p 26
###begin title 27
Trk signaling regulates promoter recruitment
###end title 27
###begin p 28
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ntrk2</italic>
###xml 569 572 569 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 572 577 572 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ntrk3</italic>
###xml 577 581 577 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 759 762 759 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 764 769 764 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 773 778 773 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 898 902 898 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a&#8211;c</xref>
###xml 1089 1091 1089 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6d</xref>
###xml 1121 1126 1121 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 1128 1134 1128 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 1138 1144 1138 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neurod</italic>
###xml 1231 1233 1231 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6e</xref>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 907 912 <span type="species:ncbi:10090">mouse</span>
The above results are consistent with Trk receptor signaling regulating either the recruitment or the activity of C/EBP and NeuroD transcription factors to target promoters. The major Trk receptors expressed in the developing central nervous system (CNS) are TrkB and TrkC, which function in a redundant manner in promoting neuronal survival during CNS development [17]. To address the role of Trk signaling in C/EBP and NeuroD promoter recruitment we performed ChIP experiments on newborn forebrains of mice lacking TrkB and one allele of the gene encoding TrkC (Ntrk2-/-Ntrk3+/- mice), thereby substantially lowering the level of neurotrophin/Trk signaling in the developing CNS. These experiments showed that the amount of C/EBPs and NeuroD present on the Fos, Egr1 and Egr2 promoters was significantly lower in forebrains where Trk signaling was reduced compared to wild-type forebrain (Figure 6a-c) or mouse forebrain lacking only TrkB (which showed an intermediate phenotype, data not shown), whereas ChIP for H3 (a control for chromatin quality) did not show any difference (Figure 6d). Importantly, expression of Cebpa, Cebpb and Neurod, as measured by qRT-PCR, was unaffected by the reduced Trk receptor signaling (Figure 6e).
###end p 28
###begin p 29
###xml 49 52 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 54 59 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 63 68 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 118 124 111 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-c) </bold>
###xml 124 132 117 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 145 148 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 150 155 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 159 164 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 231 238 224 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB/C </italic>
###xml 355 359 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB</italic>
###xml 359 362 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 362 367 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;trkC</italic>
###xml 367 371 360 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 663 665 649 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 734 740 720 726 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d,e) </bold>
###xml 761 765 747 751 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 839 843 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2</italic>
###xml 937 941 923 927 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e) </bold>
###xml 941 946 927 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 948 954 934 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 958 965 944 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neurod </italic>
###xml 1116 1120 1102 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB</italic>
###xml 1120 1123 1106 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1123 1128 1109 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;trkC</italic>
###xml 1128 1132 1114 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1175 1180 1161 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 1182 1188 1168 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 1192 1198 1178 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neurod</italic>
###xml 1223 1228 1209 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gapdh</italic>
###xml 1426 1428 1412 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 1143 1147 <span type="species:ncbi:10090">mice</span>
The presence of CEBPalpha/beta and NeuroD on the Fos, Egr1 and Egr2 promoters is dependent on Trk receptor signaling. (a-c) In vivo detection of Fos, Egr1 and Egr2 promoter occupancy by C/EBPs and NeuroD in the absence of multiple trkB/C alleles. ChIP analysis was performed three times on a pool of four newborn forebrain lysates from wild-type (wt) and trkB-/-;trkC+/- mice using antibodies specific for C/EBPalpha, C/EBPbeta, NeuroD, and acetylated-H3 (Ac-H3). Following ChIP analysis the samples were subjected to qPCR, and the DNA quantification was calculated as percentage of the input. In all cases, no PCR product was detected in the absence of DNA. The p value refers to the difference between wild-type and mutant animals. (d,e) Control experiments. (d) H3 ChIP analysis and qPCR were performed with primer pairs located in the Egr2-coding region. A similar amount of PCR product was detected in wild-type and mutant animals. (e) Cebpa, Cebpb and Neurod mRNA levels were not affected in the absence of Trk signaling. qRT-PCR was performed on total mRNA from newborn forebrain of wild-type (grey bars) and trkB-/-;trkC+/- (red bars) mice using primers specific for Cebpa, Cebpb and Neurod. After normalization to gapdh, mRNA levels were expressed relative to those for the wild-type animals, which were given the arbitrary value of 1. Error bars represent the standard error based on three independent experiments. *p < 0.05, **p < 0.002.
###end p 29
###begin title 30
###xml 37 46 33 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 50 57 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
C/EBPalpha and NeuroD form a complex in vitro and in vivo
###end title 30
###begin p 31
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 139 144 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 758 760 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7a</xref>
###xml 940 942 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1063 1073 1047 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 1302 1308 1286 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 1320 1325 1304 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 1325 1329 1309 1313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T/+ </sup>
###xml 1561 1566 1541 1546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 1566 1570 1546 1550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T/+ </sup>
###xml 1586 1588 1566 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
###xml 1676 1681 1656 1661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 1681 1685 1661 1665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T/+ </sup>
###xml 1701 1703 1681 1683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
###xml 1766 1773 1742 1749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 2309 2311 2273 2275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7c</xref>
###xml 2575 2584 2531 2540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 2860 2862 2809 2811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7d</xref>
###xml 876 881 <span type="species:ncbi:10090">mouse</span>
###xml 1063 1072 <span type="species:ncbi:411806|species:ncbi:1280|species:ncbi:78380|species:ncbi:211046|species:ncbi:193461|species:ncbi:170984|species:ncbi:507602|species:ncbi:98688">S. aureus</span>
###xml 1138 1144 <span type="species:ncbi:9986">rabbit</span>
###xml 1276 1280 <span type="species:ncbi:10090">mice</span>
###xml 1329 1333 <span type="species:ncbi:10090">mice</span>
While the Fos promoter contains consensus-binding sites for both C/EBP and Ebox proteins, a canonical consensus Ebox is not present in the Egr1 or Egr2 SRE homology regions. This, along with the observed correlation between C/EBP and NeuroD promoter recruitment, suggests that the two factors are recruited as a complex through a cognate binding site for one of the two (most likely a C/EBP). To determine whether C/EBPalpha and NeuroD were able to associate we co-transfected Q2bn cells with expression vectors for FLAG-tagged C/EBPalpha and Myc-tagged NeuroD and performed co-immopreciptiation analysis. This showed that Myc-NeuroD was efficiently co-precipitated with FLAG-C/EBPalpha, demonstrating that the two factors are able to form a complex (Figure 7a). To address the issue of whether such a complex exists under physiological conditions in neuronal cells we used a mouse strain in which a tandem affinity purification (TAP) tag [18] has been fused to the carboxyl terminus of C/EBPalpha. The TAP-tag contains an immunoglobulin (Ig)-binding domain from S. aureus protein A, which allows tagged proteins to selectively bind to a rabbit IgG-agarose matrix. Thus, nuclear extracts from E16.5 forebrain (a time point when the forebrain is enriched in neuronal cells) of mice heterozygous for the Cebpa TAP allele (CebpaT/+ mice) and wild-type controls were subjected to IgG-agarose pull-down and retained protein was analyzed for the presence of NeuroD by western blotting. As expected, the TAP-tagged C/EBPalpha isoforms were present in the pull-down of CebpaT/+ lysates (Figure 7b, lower panel). We observed that NeuroD was also selectively retained by IgG-agarose in CebpaT/+ lysates (Figure 7b, upper panel), indicating a complex formation with C/EBPalpha in vivo. While these results are fully consistent with the existence of C/EBPalpha-NeuroD complexes in forebrain neurons, we could not rule out that such complexes formed post-lysis. We therefore transfected Q2bn cells separately with FLAG-C/EBPalpha and Myc-NeuroD expression vectors and mixed lysates from these cells prior to co-immunoprecipitation. This did not lead to detectable complex formation, whereas C/EBPalpha-NeuroD complexes were readily detectable in lysates of Q2bn cells cotransfected with the two expression vectors (Figure 7c). Finally, to address the issue of whether the C/EBPalpha-NeuroD interaction was direct we performed glutathione S-transferase (GST) pull-downs using C/EBPalpha-GST fusions of the conserved carboxy-terminal bZIP or amino-terminal transactivation domain (TAD) and in vitro translated NeuroD. Of these, NeuroD associated strongly with the C/EBPalpha bZIP and only weakly with the TAD. Consistent with the high conservation of the bZIP domain between C/EBP isoforms, a GST fusion of the C/EBPbeta bZIP region was also able to pull down NeuroD (Figure 7d). Together, these results show that NeuroD can interact with C/EBPs through their conserved bZIP region. Since C/EBPalpha-NeuroD complexes can be isolated from both transfected cells and forebrain suggests that these molecules are co-expressed and interact in neurons.
###end p 31
###begin p 32
###xml 110 114 103 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 422 426 415 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 547 552 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 552 555 545 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAP</italic>
###xml 552 558 545 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>TAP</italic>/+ </sup>
###xml 956 960 935 939 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 1107 1111 1078 1082 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 1164 1173 1128 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 464 467 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
The bHLH transcription factor NeuroD co-immunoprecipitates and physically interacts with C/EBPalpha and beta. (a) Co-immunoprecipitation (IP) assay and western blot analysis. Q2bn cells were transfected as indicated, and lysates were subjected to a Co-IP assay with an anti-Flag antibody and were immunoblotted (WB) with anti-Myc and anti-Flag antibodies. Direct WB analysis was used to monitor protein expression levels. (b) WB, using an anti-NeuroD antibody, of TEV-released IgG pull down of 5 mg nuclear extracts from E16.5 forebrain of either CebpaTAP/+ (T/+, lane 1) or +/+ (lane 2) mice; 100 mug of input lysate (+/+) was loaded in lane 3. Note the specific presence of NeuroD (50 kDa) in the T/+ pull down. The blot was reprobed with an anti-C/EBPalpha antibody showing the specific pull down of C/EBPalpha (42 kDa and 30 kDa isoforms) in the T/+ sample (lane 1). C/EBPalpha in 100 mug of nuclear extract was below detectable levels by WB (lane 3). (c) NeuroD does not associate with CEBPalpha upon mixing lysates from myc-NeuroD transfected cells with lysates from flag-C/EBPalpha transfected cells.(d) Direct interaction of NeuroD to C/EBPalpha and beta. In vitro translated NeuroD was subjected to a pull down assay using the indicated GST fusion proteins: GST-alone, GST-C/EBPbeta-bZIP. GST-C/EBPalpha-bZIP., GST-C/EBPalpha-TAD. Autoradiograph revealed that NeuroD preferentially bound the bZIP domain of C/EBPalpha or beta. *Radiolabeled.
###end p 32
###begin title 33
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
C/EBP depletion leads to defective cortical dendritic differentiation in vivo
###end title 33
###begin p 34
###xml 100 102 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 114 120 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 124 130 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 189 195 185 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 199 205 195 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 232 234 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 315 321 311 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 341 347 337 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 355 360 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 360 363 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx </sup>
###xml 371 373 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 412 413 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 445 451 441 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 527 532 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 532 535 528 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx </sup>
###xml 620 621 616 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 646 647 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 684 689 680 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 690 692 686 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 829 834 825 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 834 839 830 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 839 845 835 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 845 848 841 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 849 855 845 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NesCre</italic>
###xml 855 859 851 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+</sup>
###xml 913 919 909 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 923 929 919 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 946 951 942 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 951 956 947 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 956 962 952 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 962 965 958 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/+</sup>
###xml 966 972 962 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NesCre</italic>
###xml 972 976 968 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+</sup>
###xml 982 987 978 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 987 992 983 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/l+</sup>
###xml 992 998 988 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 998 1001 994 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1002 1008 998 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NesCre</italic>
###xml 1008 1012 1004 1008 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+</sup>
###xml 1196 1202 1192 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 1206 1212 1202 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 1228 1232 1224 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8a&#8211;f</xref>
###xml 1301 1306 1297 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8g, h</xref>
###xml 1342 1347 1335 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8i, j</xref>
###xml 1375 1380 1368 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 1380 1385 1373 1378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 1385 1391 1378 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 1391 1394 1384 1387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1394 1400 1387 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NesCre</italic>
###xml 1400 1405 1393 1398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+ </sup>
###xml 1524 1529 1517 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8k, l</xref>
###xml 1842 1848 1835 1841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 1851 1857 1844 1850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 1933 1937 1926 1930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8m&#8211;r</xref>
###xml 2087 2092 2080 2085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8s, t</xref>
###xml 2182 2187 2175 2180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8u, v</xref>
###xml 2305 2307 2298 2300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 2339 2347 2332 2340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 2412 2417 2405 2410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9a, b</xref>
###xml 2497 2504 2490 2497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b</italic>
###xml 2603 2605 2596 2598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9c</xref>
###xml 62 66 <span type="species:ncbi:10090">Mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
We next addressed the role of C/EBPs in neuronal development. Mice lacking C/EBPalpha die at birth [19], combined Cebpa and Cebpb null alleles are embryonic lethal, and mice carrying three Cebpa and Cebpb null alleles die at birth [16]. Therefore, to facilitate the analysis we used conditional inactivation of the Cebpa gene using a floxed Cebpa allele (Cebpalx allele [20]) and a Nestin-Cre transgene (NesCre [5]), and mice homozygous for the Cebpb null allele. Southern blot analysis showed that NesCre recombination of the Cebpalx allele was virtually complete in the CNS at postnatal day 0 (P0; supplemental Figure 3 in Additional data file 1). Moreover, as the co-expression of Cebpa/b in neurons suggested that they could function in a redundant manner, we also combined the two mutations. In this case the double mutant (Cebpalx/lx;Cebpb-/-;NesCretg/+) died at birth, whereas mutants carrying up to three Cebpa and Cebpb deleted alleles (Cebpalx/lx;Cebpb-/+;NesCretg/+, and Cebpalx/l+;Cebpb-/-;NesCretg/+) were viable and used in this analysis. Histological analysis of P0 cortices showed no gross morphological defects or alteration of cortical layering upon inactivation of up to three Cebpa and Cebpb alleles (Figure 8a-f). Likewise, expression of the general neuronal markers NeuN (Figure 8g, h) and betaIII-tubulin (Tju1; Figure 8i, j) was not decreased even in Cebpalx/lx;Cebpb+/-NesCretg/+ cortices, nor was any difference seen in expression of the glial marker glial fibrillary acidic protein (GFAP) (Figure 8k, l). No imbalance in neuronal versus glial lineage differentiation was therefore detected. When markers specific for neuronal dendrites (microtubule-associated protein 2, MAP2) and axons (68 kDa neurofilament protein, NF68) were analyzed, MAP2 staining of cortical dendrites was not diminished upon deletion of two Cebpa or Cebpb alleles, but was severely disrupted in the absence of three alleles (Figure 8m-r). Quantification showed that loss of three alleles additionally led to a significant decrease in the amount of MAP2 present in the forebrain (Figure 8s, t); no difference in axonal NF68 staining (data not shown) or total amount of NF68 (Figure 8u, v) was observed, indicating intact axonal differentiation. Given the previously reported regulation of MAP2 by NeuroD [21], NeuroD protein expression in Cebpa/b deficient brains was investigated and found to be normal (Figure 9a, b). We also investigated whether MAP2 expression was down-regulated upon loss of Cebpa/b; this was found not to be the case, as MAP2 expression at the mRNA level was not affected (Figure 9c). We therefore propose that the observed reduction in MAP2 protein is due to loss of MAP2-containing dendritic structures. Another possibility could be defective mRNA localization and translation, leading to reduced accumulation of MAP2 protein.
###end p 34
###begin p 35
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 114 120 114 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-f) </bold>
###xml 215 223 215 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(g,i,k) </bold>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 322 327 322 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 327 333 327 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 333 336 333 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 336 343 336 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;NesCre</italic>
###xml 343 347 343 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+</sup>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 367 372 367 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 372 378 372 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 378 381 378 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 510 518 502 510 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(h,j,l) </bold>
###xml 633 635 625 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 656 662 648 654 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(m-r) </bold>
###xml 693 698 685 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 698 703 690 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 705 710 697 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 710 715 702 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 715 722 707 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;NesCre</italic>
###xml 722 726 714 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+</sup>
###xml 728 733 720 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb</italic>
###xml 733 736 725 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 742 747 734 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 747 752 739 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 752 757 744 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;cebp</italic>
###xml 757 761 749 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 835 843 827 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 852 857 844 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 857 862 849 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 862 868 854 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 868 871 860 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 871 878 863 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;NesCre</italic>
###xml 878 883 870 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+ </sup>
###xml 888 893 880 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 893 897 885 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/+</sup>
###xml 897 903 889 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 903 906 895 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 906 913 898 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;NesCre</italic>
###xml 913 918 905 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+ </sup>
###xml 923 929 915 921 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(s,u) </bold>
###xml 1016 1021 1008 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 1021 1026 1013 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 1026 1032 1018 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 1032 1035 1024 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1035 1042 1027 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;NesCre</italic>
###xml 1042 1046 1034 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+</sup>
###xml 1061 1066 1053 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 1066 1071 1058 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 1071 1077 1063 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 1077 1080 1069 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1199 1203 1187 1191 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(t) </bold>
###xml 1284 1292 1272 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 1337 1342 1325 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 1345 1347 1333 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lx</italic>
###xml 1342 1347 1330 1335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/<italic>lx</italic></sup>
###xml 1347 1352 1335 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebp</italic>
###xml 1352 1355 1340 1343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1358 1362 1346 1350 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(v) </bold>
###xml 1444 1452 1432 1440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 761 766 <span type="species:ncbi:10090">mouse</span>
###xml 1082 1086 <span type="species:ncbi:10090">mice</span>
###xml 1299 1303 <span type="species:ncbi:10090">mice</span>
###xml 1459 1463 <span type="species:ncbi:10090">mice</span>
Cortical dendritic differentiation is affected in mice carrying decreasing amounts of functional Cebpa/b alleles. (a-f) Cresyl violet staining showing a normal lamination pattern in newborn mutant and control mice. (g,i,k) Representative western blots of NeuN, Tju1, and GFAP protein levels in P0 cortices of mutant (Cebpalx/lx;Cebpb+/-;NesCretg/+) and control (Cebpalx/lx;Cebpb+/-) mice. To control for protein loading, blots were re-probed with anti-PLCgamma, anti-alpha-tubulin, and anti-Erk1 respectively. (h,j,l) Densitometric analysis of NeuN, Tju1, and GFAP protein levels in P0 cortical lysates from mutant and control mice. P > 0.05 in all cases. (m-r) MAP2 immunostaining in newborn Cebpalx/lx, Cebpalx/lx;NesCretg/+, Cebpb-/-, and Cebpalx/lx;cebp+/- mouse cortices compared to cortices with decreasing amounts of functional Cebpa/b alleles, Cebpalx/lx;Cebpb+/-;NesCretg/+ (r), Cebpalx/+;Cebpb-/-;NesCretg/+ (s). (s,u) Representative western blots of MAP2 and NF68 protein levels in P0 cortices of mutant (Cebpalx/lx;Cebpb+/-;NesCretg/+) and control (Cebpalx/lx;Cebpb+/-) mice. To control for protein loading, blots were re-probed with anti-PLCgamma and anti-Erk1 antibodies respectively. (t) Densitometric analysis of MAP2 protein levels in cortical lysates of control and Cebpa/b mutant mice (*p = 0.002, compared to control Cebpalx/lx;Cebp+/-). (v) Densitometric analyses of NF68 protein levels in cortical lysates of controls and Cebpa/b mutant mice. Soms, somatosensory cortex; CP, cortical plate; V and VI, indicate cortical layers V and VI, respectively. Arrows in (h) indicate the kDa of the bands recognized by NeuN antibodies. Scale bars: 100 mum (b-g); 50 mum (n-s).
###end p 35
###begin p 36
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB/C </italic>
###xml 68 72 68 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 101 109 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB/C </italic>
###xml 253 255 253 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 276 280 276 280 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 361 369 361 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 373 380 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB/C </italic>
###xml 393 397 393 397 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAP2 </italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 441 443 441 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 533 538 533 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 538 543 538 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 543 549 543 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 549 552 549 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 571 576 571 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 576 582 576 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 582 585 582 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 585 592 585 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;NesCre</italic>
###xml 592 596 592 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+</sup>
###xml 630 639 630 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAP2A/2B </italic>
###xml 672 681 672 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ubiquitin</italic>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
NeuroD expression is normal in Cebpa/b and trkB/C deficient brains. (a) NeuroD protein expression in Cebpa/b deficient brains or trkB/C deficient brains compared to controls. Blots were re-probed with anti-Sp3 antibodies to control for protein loading. P > 0.5 in both cases. (b) Densitometric analysis of NeuroD protein levels in cortical lysates of controls, Cebpa/b and trkB/C mutant mice. (c) MAP2 mRNA levels were not affected in Cebpa/b deficient brains. qRT-PCR was performed on total mRNA from newborn forebrains of control (Cebpalx/lx;Cebpb+/-) and mutant (Cebpalx/lx;Cebpb+/-;NesCretg/+) mice using primers specific for MAP2A/2B isoforms. After normalization to ubiquitin, mRNA levels were expressed relative to those for the control animals, which were given the arbitrary value of 1. Presented is a representative result of two independent experiments. Standard error is for three animals of each genotype.
###end p 36
###begin p 37
###xml 288 294 288 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10a, b</xref>
###xml 357 363 357 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10c, d</xref>
###xml 441 447 441 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10e, f</xref>
###xml 474 477 471 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10g</xref>
###xml 513 519 510 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10h, i</xref>
###xml 561 566 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 566 571 563 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 571 577 568 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 577 580 574 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 580 587 577 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;NesCre</italic>
###xml 587 592 584 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+ </sup>
###xml 610 615 607 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 615 620 612 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 620 626 617 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 626 630 623 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 669 675 666 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10j, k</xref>
###xml 747 753 744 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10l, m</xref>
###xml 1071 1076 1061 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 1076 1081 1066 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 1081 1087 1071 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 1087 1090 1077 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1090 1097 1080 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;NesCre</italic>
###xml 1097 1101 1087 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+</sup>
###xml 1149 1154 1139 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 1154 1159 1144 1149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 1159 1165 1149 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 1165 1169 1155 1159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1242 1245 1226 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10m</xref>
###xml 1399 1402 1377 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10n</xref>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 1101 1105 <span type="species:ncbi:10090">mice</span>
###xml 1330 1334 <span type="species:ncbi:10090">mice</span>
The possibility remained that the differences observed in dendritic differentiation reflected a developmental delay, rather than a defect. We therefore performed similar analyses with 12-week-old mice. Also in this case, cortical layering (as determined by cresyl violet staining; Figure 10a, b) and neuronal numbers (assayed by NeuN immunostaining; Figure 10c, d) were unaffected. Immunoblotting confirmed equivalent levels of NeuN (Figure 10e, f), betaIII-tubulin (Figure 10g) and the glial marker GFAP (Figure 10h, i), whereas the defect in MAP2 staining in Cebpalx/lx;Cebpb+/-;NesCretg/+ mice (compared to Cebpalx/lx;Cebpb+/- controls) was still persistent (Figure 10j, k). Immunoblotting confirmed the decrease in MAP2 protein levels (Figure 10l, m). Together, these data indicate a role for C/EBPalpha/beta in cortical dendritic differentiation. To further support this conclusion we measured the thickness of apical primary and secondary dendrites of pyramidal neurons located in the primary somatosensory cortex. The mean thickness of apical primary dendrites in Cebpalx/lx;Cebpb+/-;NesCretg/+mice was found to be reduced by 10% compared to Cebpalx/lx;Cebpb+/- controls (2.00 +/- 0.02 mum and 2.24 +/- 0.115 mum, respectively; Figure 10m). Similarly, the secondary dendrites were 7% thinner in mutants compared to control mice (0.79 +/- 0.02 mum and 0.85 +/- 0.013 mum, respectively; Figure 10n). Although the differences observed in both cases are not statically significant (p > 0.05) by ANOVA analysis, they are consistent with C/EBPs being involved in dendritic differentiation function.
###end p 37
###begin p 38
###xml 46 54 46 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 135 140 135 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;cebp</italic>
###xml 145 148 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 167 172 167 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 178 181 178 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 181 188 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;NesCre</italic>
###xml 188 192 188 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+</sup>
###xml 217 223 217 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a,b) </bold>
###xml 259 265 259 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c,d) </bold>
###xml 271 277 271 277 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e,h) </bold>
###xml 476 484 476 484 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(f,g,i) </bold>
###xml 600 606 600 606 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(j,k) </bold>
###xml 658 662 658 662 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(l) </bold>
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 748 753 748 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 753 759 753 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 759 762 759 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 762 769 762 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;NesCre</italic>
###xml 769 773 769 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/+</sup>
###xml 788 793 788 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 793 798 793 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lx/lx</sup>
###xml 798 804 798 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Cebpb</italic>
###xml 804 807 804 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 899 903 895 899 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(m) </bold>
###xml 1015 1017 1011 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1026 1032 1022 1028 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(n,o) </bold>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
Neocortical development in mice with compound Cebpa/b null alleles. Coronal sections of adult (12 weeks old) cortices of control (Cebpalx/lx;cebp+/-) and mutant (Cebpalx/lx;Cebpb+/-;NesCretg/+) mice were stained with (a,b) Cresyl violet, or immunostained for (c,d) NeuN. (e,h) Representative western blots for NeuN and GFAP protein levels in adult cortical lysates from control and mutant mice. To control for protein loading, blots were re-probed with an anti-Erk1 antibody. (f,g,i) Densitometric analysis of NeuN, Tju1, and GFAP protein levels in adult cortical lysates of control and mutant mice. (j,k) Immunostaining for MAP2 in control and mutant mice. (l) Representative western blots of MAP2 protein levels in adult cortices of mutant (Cebpalx/lx;Cebpb+/-;NesCretg/+) and control (Cebpalx/lx;Cebpb+/-) mice. To control for protein loading, blots were re-probed with anti-PLCgamma antibodies. (m) Densitometric analysis of MAP2 protein levels reveals significant decrease in mutant compared to control mice. *P = 0.019. (n,o) Mean thickness of primary and secondary dendrites of pyramidal neurons located in the primary somatosensory cortex (visualized with the Golgi method). II to VI indicate the different cortical layers. Scale bars (a-d,j,k): 100 mum.
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 365 368 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 370 375 363 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 379 384 372 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 442 449 435 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 700 707 686 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 822 825 808 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 827 832 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 836 841 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
The identification of transcriptional targets for signaling by neurotrophin receptors is fundamental to understanding the effects of neurotrophins on neuronal gene expression, differentiation and function. We here provide evidence that, in neuronal cells, C/EBPalpha and -beta form a complex with NeuroD, and that these factors are recruited to the BDNF responsive Fos, Egr1 and Egr2 promoters in a manner dependent on Trk receptor signaling in vivo. Reducing the levels of C/EBPalpha and -beta led to reduced Fos, Egr1 and Egr2 expression in response to BDNF in primary neuronal cultures, and to impaired terminal dendritic differentiation revealed by decreased levels of MAP2 in cortical dendrites in vivo. Together, these results identify NeuroD-C/EBP complexes as mediators of Trk signaling, and identify the IE genes Fos, Egr1 and Egr2 as downstream targets for this pathway.
###end p 40
###begin title 41
Nuclear mediators of neurotrophin signaling
###end title 41
###begin p 42
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 455 463 455 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 586 587 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 590 596 582 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 737 739 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 821 828 813 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1039 1041 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1158 1160 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1161 1163 1153 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1244 1251 1236 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neuroD </italic>
###xml 1349 1351 1341 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1383 1388 1375 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB </italic>
###xml 1391 1396 1383 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkC </italic>
###xml 1410 1417 1402 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neuroD </italic>
###xml 1455 1457 1447 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1636 1648 1628 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neuroD/nex1 </italic>
###xml 1818 1820 1810 1812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1821 1823 1813 1815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1886 1898 1878 1890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neuroD/nex1 </italic>
###xml 1256 1260 <span type="species:ncbi:10090">mice</span>
###xml 1295 1299 <span type="species:ncbi:10090">mice</span>
###xml 1422 1426 <span type="species:ncbi:10090">mice</span>
###xml 1662 1666 <span type="species:ncbi:10090">mice</span>
Neurotrophins have multiple functions during CNS development, and mediate neuronal survival, migration, differentiation and function. These processes require activation of specific downstream targets. For example, the PI3 kinase-AKT-Foxo pathway is important for neuronal survival downstream of growth factor-induced signaling [22], and both PI3 kinase-AKT and MAPK pathways are involved in similar functions downstream of TrkB receptor-induced signaling in vivo [15,23] whereas the phospholipase Cgamma (PLCgamma)-CamK-CREB pathway regulates hippocampal plasticity downstream of TrkB [3]. Cebpb has been previously shown to be a neuronal transcriptional target downstream of the nerve growth factor (NGF) receptor (TrkA) in PC12 cells [24]. Evidence exists indicating that NeuroD is responsive to neurotrophin signaling in vivo. NeuroD is highly expressed in different tissues, including the developing neurons of the peripheral nervous system (PNS) and CNS, reaching its highest expression during differentiation in the cerebral cortex [25]. In the PNS, NeuroD is required for survival and differentiation of inner ear sensory neurons during later stages [26,27]. The loss of these sensory neurons in the vestibular-cochlear ganglia (VCG) of neuroD null mice resembles the phenotypes found in mice lacking the receptors TrkB or TrkC (reviewed in [28]). Moreover, the expression of trkB or trkC in the VCG of neuroD null mice was significantly reduced, [26], supporting a link between NeuroD and TrkB/C in the survival of newly differentiating inner ear sensory neurons. Similarly, dentate granule neurons of the CNS fail to mature in neuroD/nex1 double mutant mice, indicating that these molecules are critical not only for the survival of early differentiating neurons, but also for their terminal differentiation [29,30]. Although no such phenotype was observed in the neocortex of neuroD/nex1 animals, this may be explained by NeuroD family members being functionally redundant.
###end p 42
###begin p 43
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 155 161 155 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 314 320 314 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ntrk2 </italic>
###xml 324 330 324 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ntrk3 </italic>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 385 386 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 673 674 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 876 884 876 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
We have identified NeuroD-C/EBP complexes as novel mediators of Trk signaling in vivo. The finding that inhibition of these complexes (through deletion of Cebpa and Cebpb alleles) has effects on cortical differentiation similar to those seen by reduction of Trk signaling during development (through disruption of Ntrk2 and Ntrk3 alleles; supplemental Figure 4 in Additional data file 1, and previous work in which we have shown that TrkB/C cooperate in promoting the survival of differentiating hippocampal and cerebellar granule neurons [17], and that TrkB regulates functions throughout the formation of the cerebral cortex, including dendrite neuronal differentiation [5]) is, furthermore, consistent with Trk signaling through NeuroD-C/EBP being required for MAP2 induction and dendrite growth. Given that C/EBPs and NeuroD are induced during neuronal lineage commitment in vitro, it is interesting to speculate that their appearance allows Trk receptor signaling to regulate genes involved in subsequent terminal neuronal differentiation and function.
###end p 43
###begin p 44
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 155 158 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 230 237 230 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 483 488 483 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
Of the targets found to be affected in this study, Fos and Egr1 have both been implicated in dendrite formation in PC12 cells [31,32]. Genetic ablation of Fos, Egr1 or Egr2 has not been reported to affect dendrite differentiation in vivo, suggesting that the combined downregulation of multiple targets leads to the observed effects on neuronal dendrite differentiation. It is, however, equally possible that some of the NeuroD-C/EBP targets are involved in neuronal function, since Egr1 has been reported to be required in the CNS for long-term synaptic plasticity (LTP) in the dentate gyrus [33]. The known functions of the affected genes are, therefore, consistent with the observed differentiation phenotype, and suggest a role for C/EBPs in the generation of LTP. However, given the possibility of functional redundancies, further genetic analysis will be required to resolve this issue.
###end p 44
###begin p 45
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 665 671 641 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 675 681 651 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
We did not observe any effects of C/EBP depletion on gross CNS morphology or the distribution or number of neurons and glial cells, as determined by histological analysis and quantification of NeuN and GFAP. Previous reports [13,14] have shown that high levels of dominant-negative C/EBP were able to inhibit neurogenesis. Our genetic data do not, at this point, confirm a role for C/EBPs in neuronal-glial lineage decisions. However, in addition to C/EBPalpha and beta, C/EBPdelta and epsilon are also expressed in the CNS and may be able to compensate for loss of the alpha and beta isoforms. In addition, due to the early embryonic lethality of mice lacking all Cebpa and Cebpb alleles, one wild-type allele was intact in our analysis, which may be sufficient for any commitment step. It should be noted that the use of high levels of dominant negative C/EBPs may affect other related transcription factors (such as C/ATF and CREB/CREM), and confirmation of the proposed C/EBP function in neuronal lineage commitment by genetic means will still be important to finally resolve this issue.
###end p 45
###begin title 46
Recruitment of C/EBP-NeuroD complexes to target promoters
###end title 46
###begin p 47
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 144 149 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr1 </italic>
###xml 153 158 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egr2 </italic>
###xml 261 269 254 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 556 560 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 591 595 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
###xml 358 363 <span type="species:ncbi:10090">mouse</span>
The promoter elements in the Fos, Egr1 and Egr2 promoters that recruit C/EBPalpha/beta and NeuroD have significant homology, but in the case of Egr1 and Egr2 do not contain a consensus Ebox. This raises the possibility that the C/EBP-NeuroD complexes that form in vivo in neuronal cells expressing these factors (as determined by TAP-mediated pull down from mouse forebrain tissue) are recruited through a single binding site for C/EBP, with little or no interaction between NeuroD and DNA. This notion is supported by the observation that mutation of the Fos promoter Ebox had no effect on Fos promoter activity in transient transfection assays, whereas simultaneous mutation of both the C/EBP site and the Ebox significantly decreased promoter induction by BDNF.
###end p 47
###begin p 48
###xml 80 88 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 155 160 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ntrk2</italic>
###xml 161 166 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ntrk3</italic>
###xml 489 494 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 495 501 488 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 1164 1173 1157 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1312 1314 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1398 1400 1388 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1401 1403 1391 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1592 1594 1582 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
The recruitment of NeuroD and C/EBPalpha/beta to IE gene promoters was impaired in vivo when the levels of Trk signaling were decreased by inactivation of Ntrk2/Ntrk3. This result demonstrates that Trk-mediated signaling regulates the association of these factors with chromatin, and the observation that NeuroD and C/EBP recruitment were highly correlated is consistent with these factors being recruited as a complex, as discussed above. Importantly, lowering the level of C/EBP through Cebpa/Cebpb inactivation decreased the inducibility of all three IE gene promoters in response to BDNF, providing a direct link between the level of C/EBP (and by inference C/EBP-NeuroD complexes) available and neurotrophin-mediated gene activation. While C/EBPs, therefore, are an essential component of TrkB/TrkC mediated IE gene activation, the events linking Trk signaling to C/EBP and/or NeuroD remain to be fully understood at this point. Both C/EBPs and NeuroD are known to be phosphorylated in response to extracellular signaling; however, the physiological relevance of these phosphorylation events are yet to be addressed genetically. Perhaps most relevantly, from in vitro studies, phosphorylation of C/EBPbeta Thr188 by ERK, and Thr217 by ribosomal S6 kinase (Rsk), both of which are kinases downstream of MEK [34], have been proposed to be required for their role in neuronal lineage commitment [13,14]. We find that Trk-mediated IE gene induction depends on the Shc adaptor-binding site, a principal function of which is to mediate high-level sustained ERK activation in cultured neurons [15]. It is therefore possible that, also in the context of a NeuroD-C/EBP complex, this pathway regulates C/EBP activity. Experiments to address this question genetically are currently underway.
###end p 48
###begin p 49
###xml 73 81 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 85 91 81 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vit</italic>
###xml 304 306 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
In summary, we have shown here that C/EBPalpha and NeuroD form complexes in vivo and in vitro. These may define a novel class of C/EBP-bHLH transcription factor complexes of widespread importance, as we have recently shown that a similar interaction occurs between C/EBPalpha and SREBP-1 in hepatocytes [35]. ChIP analysis and genetic depletion demonstrated that recruitment of C/EBP and NeuroD to IE gene promoter chromatin occurred concurrently in a Trk-dependent manner, and was required for IE gene induction by neurotrophins. The physiological result of C/EBP depletion was reduced MAP2 expression and impaired cortical dendritic differentiation. We have, therefore, identified C/EBP-NeuroD complexes as novel mediators of Trk signaling, and provide evidence that such complexes function in late stages of neuronal development to promote terminal neuronal differentiation.
###end p 49
###begin title 50
Materials and methods
###end title 50
###begin title 51
RNA preparation for microarray analysis and RT-PCR
###end title 51
###begin p 52
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB</italic>
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHC</italic>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHC </italic>
###xml 60 68 60 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>SHC</italic>/<italic>SHC </italic></sup>
###xml 721 722 721 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 355 361 <span type="species:ncbi:10090">Murine</span>
RNA was isolated from E15.5 cortical neurons of +/+ and trkBSHC/SHC mice with TRIzol according to the protocol supplied by the manufacturer (GIBCO Life Technologies (now Invitrogen), Milan, Italy), and labeled according to the one-cycle eukaryotic target labeling protocol from Affymetrix (Santa Clara, CA, USA). The samples were hybridized to Affymetrix Murine Genome U74Av2 GENEChips. For RT-PCR or qPCR, cDNA was prepared from total RNA using random hexamer primers and MuLV reverse transcriptase (Roche, Milan, Italy) or Ready-to-go T-primed First Strand Kit (Amersham Biosciences, Milan, Italy) as described by the manufacturers. The sequences of the primers used for the different PCR reactions are listed in Table 1.
###end p 52
###begin p 53
Primer sequences used for RT-PCR, q PCR and ChIP
###end p 53
###begin p 54
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
For the ChIP experiments the same primers were used for both PCR and qPCR except where noted. *Additional primers used for Fos qPCR after ChIP. CD, coding region; UTR, untranslated region.
###end p 54
###begin title 55
DNA constructs
###end title 55
###begin p 56
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 458 461 458 461 <underline xmlns:xlink="http://www.w3.org/1999/xlink">cgg</underline>
###xml 508 511 508 511 <underline xmlns:xlink="http://www.w3.org/1999/xlink">acg</underline>
###xml 555 556 555 556 <underline xmlns:xlink="http://www.w3.org/1999/xlink">a</underline>
###xml 613 616 609 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 619 622 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 676 685 672 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 695 697 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 857 860 853 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 925 928 921 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 747 752 <span type="species:ncbi:10090">Mouse</span>
The constructs pMSRF/cebp, pMcebp/ebox, and pMebox were created as previously described [36]. Mutations in the pMSRF/cebp and pMcebp/ebox constructs were introduced as described [37], whereas for the pMebox construct the QuickChange Site-directed Mutagenesis Kit was used (Stratagene, Milan, Italy). The oligonucleotide primers used to generate pMSRF/cebp, pMcebp/ebox and pMebox constructs carried the following mutations (underlined), respectively: tgtccatcggaggacatctgcgtcagcaggtttccacggcc, tgtccatattaggaacgctgcgtcagcaggtttccacggcc, and tgtccatattaggaaatctgcgtcagcaggtttccacggcc. C/EBPalpha was introduced as BamHI-EcoRI fragments in pcDNAI (Invitrogen, Milan, Italy) for in vitro labeling [38], and in pcDNA3.1 (Invitrogen) for transfection. Mouse NeuroD full-length cDNA was obtained by RT-PCR using RNA isolated from cortical neurons and the primers BamHI/5'-cgggatccgtggaaacatgacc-3' and 5'-ggaattcactgacgtgcctcta-3'/EcoRI.
###end p 56
###begin title 57
Cultures of cortical progenitors and postmitotic neurons
###end title 57
###begin p 58
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 795 799 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB</italic>
###xml 799 802 799 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHC</italic>
###xml 803 807 803 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHC </italic>
###xml 799 807 799 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>SHC</italic>/<italic>SHC </italic></sup>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 183 188 <span type="species:ncbi:10090">mouse</span>
###xml 744 749 <span type="species:ncbi:10090">mouse</span>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
Cortical progenitors, as well as postmitotic neurons, from mouse embryos were cultured according to previously described methods [15,39]. Briefly, cortices were collected from E12-13 mouse embryos, triturated, and then plated on poly-L-lysine (at different densities depending on the final experiment). The culture medium consisted of Neurobasal medium (GIBCO BRL (now Invitrogen), Milan, Italy), 0.5 mM glutamine, penicillin-streptomycin, 1% N2 supplement (GIBCO BRL), and basic fibroblast growth factor (bFGF) (40 ng/ml; R&D Systems, Milan, Italy). After 48 hours, medium was replaced with the same medium containing 2% B27 supplement (GIBCO BRL) instead of 1% N2 supplement. Postmitotic neurons were prepared from cerebral cortices of E15.5 mouse embryos derived from crosses of wild-type or trkBSHC/SHC homozygous mice. Cortical neurons were cultured and BDNF stimulated as described [15]. Purified recombinant BDNF (Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA) was added to the culture medium at a concentration of either 5 or 50 ng/ml, as indicated.
###end p 58
###begin title 59
Immunocytochemistry
###end title 59
###begin p 60
###xml 461 466 <span type="species:ncbi:10090">mouse</span>
###xml 544 549 <span type="species:ncbi:10090">mouse</span>
###xml 624 629 <span type="species:ncbi:9796">horse</span>
###xml 800 804 <span type="species:ncbi:9925">goat</span>
###xml 810 815 <span type="species:ncbi:10090">mouse</span>
Cortical progenitors after either 1 or 4 days in vitro (DIV) were fixed in 4% paraformaldehyde (PFA) for 20 minutes. Washes were performed with 10 mM phosphate-buffered saline (PBS)/glycine to neutralize the PFA. The cells were permeabilized with 0.5% NP-40/PBS for 5 minutes. Blocking solution was added for 1 hour (10% NHS, 0.3% Carrageenan Lambda (Sigma, Milan, Italy), 0.5% TritonX100 in 50 mM TBS) at room temperature, followed by incubation with either a mouse monoclonal anti-MAP2 antibody (1:300, clone AP20, ChemiconMilan, Italy) or a mouse monoclonal anti-Nestin antibody (1:300, clone 401, Chemicon) in 1% normal horse serum (NHS), 0.3% Carrageenan Lambda, 0.5% TritonX100, 50 mM Tris-buffered saline (TBS), O/N at 4degreesC. Immunostainings were visualized using a fluorescein-conjugated goat anti-mouse IgG (H+L) (1:200 in TBS, Jackson IR, Milan, Italy). The slides were mounted with Vectashield mounting medium (Vector H2000, Milan, Italy).
###end p 60
###begin title 61
Transfection of cortical neurons and luciferase assay
###end title 61
###begin p 62
###xml 38 40 38 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 363 379 <span type="species:ncbi:562">Escherichia coli</span>
Cortical neurons were plated at 3 x 106 cells per 60 mm well. Transfections were carried out on either 3 or 4DIV using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's protocol. Briefly, one 60 mm well of cells was transfected with 2.3 mug of reporter plasmid plus 3 mug of the plasmid ras sarcoma virus long terminal repeat containing the Escherichia coli beta-galactosidase gene (pRSV-beta-gal). Then, 24 hours after transfection, cells were left unstimulated or stimulated with 50 ng/ml of BDNF for 2 hours. Cells were then lysed in 250 mul of Triton lysis buffer (100 mM potassium phosphate pH 7.8, 0.2% Triton X-100, 1 mM dithiothreitol (DTT)). Cell debris was removed by centrifugation, and the lysates were used in luciferase and beta-gal assays. The luciferase activity was measured using a Lumat LB 9507 luminometer (Berthold Technologies Wildbad, Germany). The fold induction was defined as the ratio of beta-gal normalized luciferase activity in lysates of stimulated cells relative to the normalized luciferase activity from unstimulated cells.
###end p 62
###begin title 63
Co-transfection assay
###end title 63
###begin p 64
###xml 160 164 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos </italic>
Plasmids used for cotransfections included pcDNA3.1 (Invitrogen) driving the expression of C/EBPalpha or NeuroD, and a wild type (pWT) or mutated (pMcebp/ebox) Fos promoter driving expression of luciferase. NIH3T3 cells were grown to 60% to 80% confluence in 30 mm wells and transfected with a total of 1.5 mug of DNA including 250 ng of the luciferase reporter plasmid and 250 ng of pRSV-beta-gal plasmid for normalization. Cells were transfected using FuGENE 6 (Roche) according to the manufacturer's protocol. After 24 hours, cells were harvested, lysed, and the beta-galactosidase and luciferase activities were measured as described above.
###end p 64
###begin title 65
Co-immunoprecipitation assay and western analysis
###end title 65
###begin p 66
###xml 434 435 430 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1221 1227 1209 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 1231 1237 1219 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 1295 1297 1283 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 251 257 <span type="species:ncbi:9913">bovine</span>
###xml 271 278 <span type="species:ncbi:9031">chicken</span>
###xml 1181 1186 <span type="species:ncbi:10090">mouse</span>
###xml 1414 1420 <span type="species:ncbi:9986">rabbit</span>
pCMV-Tag3 vector (Stratagene, Milan, Italy) was used to express NeuroD possesssing one Myc-epitope tag, and pcDNA3.1 (Invitrogen) was used to express C/EBPalpha possessing one Flag-epitope tag. Q2bn cells were grown in DMEM supplemented with 8% fetal bovine serum and 2% chicken serum, transfected using calcium phosphate, and harvested 24 hours after transfection. Cells were disrupted in lysis buffer (50 mM Tris pH 7.4, 1.5 mM MgCl2, 100 mM NaCl, 0.5% Triton X-100) supplemented with a protease inhibitor cocktail (Roche) on ice for 15 minutes, and then incubated at room temperature for 30 minutes with 0.25 u/mul of benzonase (Sigma). After clarification by centrifugation, lysates were subjected to Co-IP using 20 mul of anti-Flag M2 affinity gel beads (Sigma) at 4degreesC overnight (O/N). The beads were collected and washed, and the bound proteins were eluted by a competition with 3X FLAG peptide (Sigma), and analyzed by SDS-PAGE followed by western blotting using anti-Myc tag antibody (1:2000, Ab9106, Abcam, Cambridge, UK) and anti-Flag tag antibody (1:2500, Sigma). Analysis of pERK1/2 and pAKT in stimulated cortical neurons derived from cerebral cortices of E12.5 mouse embryos of controls and different Cebpa and Cebpb mutants was carried out using western blots as described [15]. The monoclonal anti-pERK1/2 antibody was used at 1:2000 (clone E10, New England Biolabs, Frankfurt, Germany), the rabbit polyclonal anti-pAKT (Ser473) was used at 1:1000 (Cell Signaling, Frankfurt, Germany), and the monoclonal anti-alpha-tubulin antibody was used at 1:20.000 (clone DM1A, Sigma).
###end p 66
###begin title 67
GST pull down assay
###end title 67
###begin p 68
###xml 292 294 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 297 299 279 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 367 369 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 744 746 723 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 58 65 <span type="species:ncbi:9031">chicken</span>
###xml 124 127 <span type="species:ncbi:10116">rat</span>
###xml 590 596 <span type="species:ncbi:9913">bovine</span>
The GST fusions C/EBPbeta bZIP (amino acids 231 to 328 of chicken C/EBPbeta) and C/EBPalpha bZIP (amino acids 256 to 358 of rat C/EBPalpha) were constructed by PCR amplification and cloning into pGEX4T-1 (Pharmacia, Milan, Italy). GST C/EBPalpha TAD (amino acids 1 to 96) has been described [40]. 35S-labeled NeuroD was prepared using the Promega TNT T7 system and L-35S-methionine (Amersham Biosciences) according to the manufacturer's suggestions. Pull down experiments were carried out by pre-incubating 100 mul of bead suspension (corresponding to about 500 ng protein) with 50 mul 10% bovine serum albumin (BSA) and 350 mul pull down buffer (50 mM Tris pH 8, 250 mM NaCl, 0.5% NP40) for 30 minutes at room temperature with gentle shaking. 35S-labeled protein (5 mul) was subsequently added, and the incubation was continued for 1 hour. The beads were then washed 3 times with ice-cold NETN buffer (0.1 M NaCl, 1 mM EDTA, 10 mM Tris pH 8.0, 0.5% NP40), pelleted, and resuspended in 20 mul of 2X SDS buffer (20% glycerol, 4% SDS, 10% beta-mercaptoethanol, 125 mM Tris-Cl pH 6.8, 0.2% bromophenol blue). The samples were boiled for 5 minutes, and the beads were pelleted. The supernatants were resolved by SDS-PAGE (12.5%). Labeled proteins were detected on a Fuji BAS2040 phosphorimager (Milan, Italy).
###end p 68
###begin title 69
Tandem affinity purification
###end title 69
###begin p 70
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa</italic>
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAP</italic>
###xml 25 31 25 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>TAP</italic>/+ </sup>
###xml 422 423 416 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 926 932 <span type="species:ncbi:9986">rabbit</span>
###xml 1104 1107 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
###xml 1198 1201 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
Wild-type (+/+) and CebpaTAP/+ (T/+) E16.5 forebrains were dissected, and then lysed in hypotonic buffer (25 mM Tris pH 7.4, 50 mM KCl, 2 mM MgCl2, 1 mM EDTA, 1 mM DTT, protease inhibitors from Sigma) for 20 minutes on ice. The samples were centrifuged at 4,000 rpm for 20 minutes at 4degreesC to collect the nuclei, which were washed in hypotonic buffer and resuspended in benzonase buffer (50 mM Tris pH 7.4, 1.5 mM MgCl2, 100 mM NaCl, 10% glycerol and 1 mM DTT and protease inhibitors). Benzonase (Novagen, Milan, Italy) was then added at 0.25 u/mul and left at room temperature for 25 minutes, after which lysates were supplemented with 0.2% NP40 and left on ice for 10 minutes. The nuclear extracts were collected by centrifugation at 14,000 rpm at 4degreesC for 20 minutes, and 5 mg of this were used in IP after a pre-clearing step with proteinA sepharose beads (Pharmacia) at 4degreesC for 30 minutes. We added 20 mul rabbit IgG agarose beads (Sigma) to the extracts and incubated them with gentle rocking at 4degreesC for 2 hours. The beads were washed three times with lysis buffer followed by TEV protease buffer (10 mM Hepes-KOH pH 8.0, 150 mM NaCl, 0.1% NP-40, 0.5 mM EDTA, 1 mM DTT). TEV protease (Invitrogen) was then added at 0.3 u/mul and left overnight at 4degreesC. Proteins in the supernatant of centrifuged samples were precipitated using acetone, dissolved in 20 mul of sample buffer, and loaded on a 10% SDS-PAGE gel. Western blot analysis was performed using an anti-NeuroD antibody (1:500; D-20, SantaCruz, Milan, Italy) in 5% BSA. Stripped membranes were re-probed with an anti-C/EBPalpha antibody (1:500; 14AA, SantaCruz).
###end p 70
###begin title 71
ChIP analysis
###end title 71
###begin p 72
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1163 1164 1142 1143 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1745 1746 1709 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 751 757 <span type="species:ncbi:9986">rabbit</span>
ChIP assays were performed essentially as previously described [41]. E16.5 or P0 wild-type mouse forebrains were quickly dissected, cut into small pieces, and incubated for 10 minutes in 1% PFA at 37degreesC. The tissues were collected, washed in PBS, and resuspended in lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl pH 8.1) containing 1 mM phenylmethylsulphonyl fluoride (PMSF) and 2 mg/ml aprotinin. After sonication, lysates were cleared by centrifugation and diluted 10-fold with dilution buffer (0.01% SDS, 1% Triton 100X, 1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.1, 150 mM NaCl). After a preclearing step using a salmon sperm DNA/ProteinA agarose slurry (50% slurry, Upstate, Milan, Italy), the chromatin was incubated O/N at 4degreesC with either rabbit Ig, or 2 mul of C/EBPalpha (14AA, SantaCruz), C/EBPbeta (#3082 polyclonal, Cell Signaling), NeuroD (Santa Cruz), histone H3 (Abcam), or acetylated histone H3 (Upstate) antibodies. IP complexes were collected using protein A/G sepharose beads, and washed twice with dilution buffer, once with 500 mM NaCl, and once with Tris-EDTA buffer. After the final wash, 250 mul of elution buffer (1% SDS, 0.1 M NaHCO3) was added, and the beads were rotated at room temperature for 15 minutes. The elute was supplemented with 5 M NaCl and incubated for 4 hours at 65degreesC to reverse the formaldehyde cross-linking. To analyze the DNA, samples were treated with 40 ng/mul of proteinase K (Merck, Milan, Italy) for 1 hour at 45degreesC, extracted with phenol:chloroform, and ethanol-precipitated in the presence of glycogen as carrier. The final IP DNA products were resuspended in 20 mul of 10 mM Tris-HCl and 1 mM EDTA, of which 2 mul was used for PCR analysis with 50 pmol of each primer (Table 1) in a final volume of 50 mul.
###end p 72
###begin title 73
Quantitative PCR
###end title 73
###begin p 74
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 302 303 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 350 352 350 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c </sub>
###xml 563 565 559 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c </sub>
###xml 606 608 602 604 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c </sub>
###xml 658 660 654 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c </sub>
###xml 822 832 818 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;(Tc) </sup>
###xml 970 972 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
qPCR or qRT-PCR was performed using the DyNAmoSYBR Green qPCR kit according to the manufacturer's protocol (Finnzymes, Milan, Italy) using the primers indicated in Table 1. For the ChIP, serial dilutions of IP DNA were subjected to real time PCR. After running the qPCR reactions, crossing threshold (Tc) values were determined for each sample. The Tc value was defined as the cycle at which the fluorescence rises above a baseline threshold, using iCycler software (MJ Research, Cambridge, MA). To normalize for variations in the amount of starting DNA, a DeltaTc value was calculated by subtracting the Tc value for the immunoprecipitated sample from the Tc value for the corresponding input DNA. DNA quantities were then expressed as percentages of corresponding input using the ChIP sample as a percentage of input = 2Delta(Tc) x 100. Only when IP samples contained > 1.5 times as much DNA as the Ig samples were they considered to have sufficient DNA for analysis [42].
###end p 74
###begin title 75
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
Transgenic mouse strains
###end title 75
###begin p 76
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkC</italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB</italic>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHC </italic>
###xml 66 70 66 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>SHC </italic></sup>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 161 167 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 307 313 307 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpb </italic>
###xml 425 432 425 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa (</italic>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 644 646 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 562 567 <span type="species:ncbi:10090">mouse</span>
The methods used to generate the knockouts of trkB, trkC, and trkBSHC have been previously described [15,17], as well as those used to generate the knockouts of Cebpa (generously provided by Drs D Tenen (Harvard University, Boston MA, USA) and G Darlington (Baylor College of Medicine, Houston TX, USA) and Cebpb (generously provided by Drs PF Johnson and E Sterneck (National Cancer Institute, Bethesda DC, USA), the floxed Cebpa (generously provided by Dr YH Lee, Institute of Molecular Biology, Accademia Sinica, Taipei, Taiwan), and the transgenic NestinCre mouse lines [5,19,20,43]. The C/EBPalpha-C-TAP strain was generated according to [18] (O Ermakova and C Nerlov, unpublished data).
###end p 76
###begin title 77
Histology and protein expression levels
###end title 77
###begin p 78
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 733 741 722 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa/b </italic>
###xml 745 752 734 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trkB/C </italic>
###xml 818 819 807 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1251 1253 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1512 1513 1500 1501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Histological and immunohistochemical (IHC) analyses were carried out as described previously [3]. Brain tissue biochemistry was performed as described [5]. The specific antibodies used to evaluate neuronal differentiation were NeuN (1:500 WB, 1:100 IHC, clone A60, Chemicon), betaIII-tubulin (1:10,000, clone Tuj.1, AbCam), GFAP (H-50; 1:500, polyclonal, Santa Cruz), MAP2 (1:300, clone AP20, Chemicon) and NF68 (AB1983; 1:250, polyclonal, Chemicon). The antibodies anti-PLCgamma-1 (1:2,000, mixed monoclonal, Upstate), anti-Erk1 (1:3,000, monoclonal, Zymed, Milan, Italy), and anti-alpha-tubulin (1:20,000, clone DM1A, Sigma) were used to control for protein loading. For the analysis of NeuroD protein expression, P0 cortices from Cebpa/b and trkB/C mutants and controls were lysed in (50 mM Tris pH 7.4, 1.5 mM MgCl2, 100 mM NaCl, 0.5% Triton X-100) supplemented with a protease inhibitor cocktail (Roche) on ice for 15 minutes, and then incubated at room temperature for 30 minutes with 0.25 u/mul of benzonase (Sigma). Western blot analysis was performed using an anti-NeuroD antibody (1:500, D-20, SantaCruz) in 5% BSA. Stripped membranes were re-probed with an anti-SP3 antibody (D-20X; 1:1,000, polyclonal, SantaCruz). Densitometric analysis [44] of imaged blots was used to compare the expression levels of proteins in mutant and control brains, and was performed on three different blots for each antibody. The ratios obtained for mutant and control samples were compared statistically using Student's t-test.
###end p 78
###begin title 79
Golgi method and analysis of dendritic thickness
###end title 79
###begin p 80
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 585 586 585 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were perfused with 4% PFA in phosphate buffer. Brains were dissected and post-fixed in 4% PFA. Golgi staining was performed according to the Golgi-Kopsch method, as described previously [45]. Briefly, blocks of brain tissue (approximately 2.5 mm thickness) were prepared and soaked in a solution containing 2.5% potassium-dichromate for 1 day at room temperature in the dark. The solution was then replaced with fresh of 2.5% potassium-dichromate solution, and tissues were incubated for another 6 days. Tissues were then washed and transferred to a solution containing 0.75% AgNO3. After 5 to 6 days, brain pieces were removed, washed in 40% and 20% ethanol, and cut into 80 mum coronal sections using a vibratom (Leica, Heidelberg, Germany). Sections were mounted on gelatin-coated slides and coverslipped with Merkoglas (Merk, Darmstadt, Germany). Analysis of dendritic thickness was performed on Golgi-impregnated sections that were uniformly dark throughout the section. Only dendrites that displayed no breaks in their staining, and were not masked by other neurons or artifacts, were evaluated. Quantitative three-dimensional analyses were performed using a combined hardware-software system (NeuroLucida, Microbrightfields Inc., Colchester, VT, USA) controlling the x-y-z axis of the microscope (Axioscop Imaging, Zeiss, Rehlingen, Germany), and a microscope-mounted video camera (Hitachi, Tokyo, Japan). The three-dimensional reconstruction was done using a 100x objective (NA: 1.4; oil immersion) and the NeuroLucida system. Mean dendritic thickness was calculated from the reconstructed dendrites with the help of NeuroExplorer (Microbrightfields Inc.). The mean, standard deviation (SD), and standard error of the mean (SEM) were calculated. ANOVA followed by a Newman-Keuls test were used for statistical analysis, and were performed using Prism 4.0 (Graph Pad, San Diego, USA).
###end p 80
###begin title 81
Authorization for the use of experimental animals
###end title 81
###begin p 82
The EMBL-Monterotondo Animal Ethics Committee approved all animal procedures. We further confirm that all animal experiments conformed to Italian and European regulatory standards.
###end p 82
###begin title 83
Competing interests
###end title 83
###begin p 84
The author(s) declare that they have no competing interests.
###end p 84
###begin title 85
Authors' contributions
###end title 85
###begin p 86
###xml 520 529 520 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
AMC participated in the design of the study and performed the molecular biology, biochemical and genetic experiments, and the statistical analysis. CN was involved in revising the manuscript critically, and contributed to the molecular biology experiments. RGL contributed to the molecular genetics experiments. CS contributed to the biochemical and molecular genetics experiments, and participated in the sequence alignment. OBH performed the Golgi method and analysis of dendritic thickness. OB has contributed to the in vitro biochemical analysis of the C/EBP-NeuroD complex. LM conceived the study, participated in its design and coordination, and drafted the manuscript. All authors have read and approved the final manuscript.
###end p 86
###begin title 87
Supplementary Material
###end title 87
###begin title 88
Additional file 1
###end title 88
###begin p 89
Four supplementary figures.
###end p 89
###begin p 90
Click here for file
###end p 90
###begin title 91
Additional file 2
###end title 91
###begin p 92
Additional Materials and methods.
###end p 92
###begin p 93
Click here for file
###end p 93
###begin title 94
Acknowledgements
###end title 94
###begin p 95
We wish to thank Dr E Reuvni for the promoter sequence analysis, and E Perlas for excellent technical assistance, and Regeneron Pharmaceutical Inc. for providing recombinant BDNF. This study was supported in part by a grant from the European Union (EuroStemCell) to LM and CN. OvBuH was supported by the Deutsche Forschungsgemeinschaft (SFB 636/A5).
###end p 95
###begin article-title 96
Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system
###end article-title 96
###begin article-title 97
Essential role for TrkB receptors in hippocampus-mediated learning
###end article-title 97
###begin article-title 98
Mecchanisms of TrkB-mediated hippocampal long-term potentiation
###end article-title 98
###begin article-title 99
Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites
###end article-title 99
###begin article-title 100
TrkB regulates neocortex formation through the Shc/PLCgamma-mediated control of neuronal migration
###end article-title 100
###begin article-title 101
Basic helix-loop-helix factors in cortical development
###end article-title 101
###begin article-title 102
NeuroD: the predicted and the surprising
###end article-title 102
###begin article-title 103
A CaMKII-NeuroD signaling pathway specifies dendritic morphogenesis
###end article-title 103
###begin article-title 104
Neural bHLH genes control the neuronal versus glial fate decision in cortical progenitors
###end article-title 104
###begin article-title 105
Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms
###end article-title 105
###begin article-title 106
Biological role of the CCAAT/enhancer-binding protein family of transcription factors
###end article-title 106
###begin article-title 107
CCAAT/enhancer-binding proteins: structure, function and regulation
###end article-title 107
###begin article-title 108
An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis
###end article-title 108
###begin article-title 109
###xml 117 124 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
CCAAT/enhancer-binding protein phosphorylation biases cortical precursors to generate neurons rather than astrocytes in vivo
###end article-title 109
###begin article-title 110
Point mutation in trkB causes loss of NT4-dependent neurons without major effects on diverse BDNF responses
###end article-title 110
###begin article-title 111
Essential requirement of CCAAT/enhancer binding proteins in embryogenesis
###end article-title 111
###begin article-title 112
TrkB and TrkC neurotrophin receptors cooperate in promoting survival of hippocampal and cerebellar granule neurons
###end article-title 112
###begin article-title 113
A generic protein purification method for protein complex characterization and proteome exploration
###end article-title 113
###begin article-title 114
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Impaired energy homeostasis in C/EBP alpha knockout mice
###end article-title 114
###begin article-title 115
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
Disruption of the c/ebp alpha gene in adult mouse liver
###end article-title 115
###begin article-title 116
###xml 30 35 <span type="species:ncbi:9606">human</span>
Transcriptional regulation of human MAP2 gene in melanoma: role of neuronal bHLH factors and Notch1 signaling
###end article-title 116
###begin article-title 117
The many forks in FOXO's road
###end article-title 117
###begin article-title 118
Distinct requirements for TrkB and TrkC signaling in target innervation by sensory neurons
###end article-title 118
###begin article-title 119
Abstract CCAAT/enhancer binding protein beta is a neuronal transcriptional regulator activated by nerve growth factor receptor signaling
###end article-title 119
###begin article-title 120
Expression of neuroD/BETA2 in mitotic and postmitotic neuronal cells during the development of nervous system
###end article-title 120
###begin article-title 121
###xml 12 16 <span type="species:ncbi:10090">mice</span>
NeuroD-null mice are deaf due to a severe loss of the inner ear sensory neurons during development
###end article-title 121
###begin article-title 122
Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems
###end article-title 122
###begin article-title 123
Effects of neurotrophin and neurotrophin receptor disruption on the afferent inner ear innervation
###end article-title 123
###begin article-title 124
Neuronal basic helix-loop-helix proteins (NEX and BETA2/Neuro D) regulate terminal granule cell differentiation in the hippocampus
###end article-title 124
###begin article-title 125
NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus
###end article-title 125
###begin article-title 126
c-Fos activated phospholipid synthesis is required for neurite elongation in differentiating PC12 cells
###end article-title 126
###begin article-title 127
ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1
###end article-title 127
###begin article-title 128
A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories
###end article-title 128
###begin article-title 129
Transcriptional regulation by MAP kinases
###end article-title 129
###begin article-title 130
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Distinct C/EBP motifs regulate lipogenic and gluconeogenic gene expression in vivo
###end article-title 130
###begin article-title 131
###xml 84 89 <span type="species:ncbi:9606">human</span>
A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation
###end article-title 131
###begin article-title 132
Three levels of functional interaction determine the activity of CCAAT/enhancer binding protein-alpha on the serum albumin promoter
###end article-title 132
###begin article-title 133
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo
###end article-title 133
###begin article-title 134
Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination
###end article-title 134
###begin article-title 135
###xml 140 145 <span type="species:ncbi:4932">yeast</span>
CCAAT/enhancer binding protein-alpha amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells
###end article-title 135
###begin article-title 136
Rb Interacts with histone deacetylase to repress transcription
###end article-title 136
###begin article-title 137
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
Chromatin immunoprecipitation technique for study of transcriptional dysregulation in intact mouse brain
###end article-title 137
###begin article-title 138
An essential role for C/EBPbeta in female reproduction
###end article-title 138
###begin article-title 139
NIH Image
###end article-title 139
###begin article-title 140
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Age-related alterations in hippocampal spines and deficiencies in spatial memory in mice
###end article-title 140

